NCT02145403 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 41
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 51
- units
- Participants
- groups
- description
- Participants were administered 20 mg/m\^2 of Carfilzomib on days 1, 2, 6 and 7.
- id
- BG000
- title
- Dose Level 1 - Maximum Dose Carfilzomib 20 mg/m^2
- description
- Participants were administered 20 mg/m\^2 on days 1 and 2; 27 mg/m\^2 of Carfilzomib on days 6 and 7.
- id
- BG001
- title
- Dose Level 2 - Maximum Dose Carfilzomib 27 mg/m^2
- description
- Participants were administered 20 mg/m\^2 on days 1 and 2; 36 mg/m\^2 of Carfilzomib on days 6 and 7.
- id
- BG002
- title
- Dose Level 3 - Maximum Dose Carfilzomib 36 mg/m^2
- description
- Participants were administered 20 mg/m\^2 on days 1 and 2; 45 mg/m\^2 of Carfilzomib on days 6 and 7.
- id
- BG003
- title
- Dose Level 4 - Maximum Dose Carfilzomib 45 mg/m^2
- description
- Total of all reporting groups
- id
- BG004
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 29
- upper Limit
- 60
- value
- 32
- group Id
- BG001
- lower Limit
- 51
- upper Limit
- 61
- value
- 55
- group Id
- BG002
- lower Limit
- 26
- upper Limit
- 69
- value
- 58
- group Id
- BG003
- lower Limit
- 53
- upper Limit
- 64
- value
- 60
- group Id
- BG004
- lower Limit
- 26
- upper Limit
- 69
- value
- 58
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 22
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 24
- title
- Female
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 19
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 27
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 39
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 49
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 2
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 41
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 51
- units
- Participants
- groups
- description
- Participants were administered 20 mg/m\^2 of Carfilzomib on days 1, 2, 6 and 7.
- id
- BG000
- title
- Dose Level 1 - Maximum Dose Carfilzomib 20 mg/m^2
- description
- Participants were administered 20 mg/m\^2 on days 1 and 2; 27 mg/m\^2 of Carfilzomib on days 6 and 7.
- id
- BG001
- title
- Dose Level 2 - Maximum Dose Carfilzomib 27 mg/m^2
- description
- Participants were administered 20 mg/m\^2 on days 1 and 2; 36 mg/m\^2 of Carfilzomib on days 6 and 7.
- id
- BG002
- title
- Dose Level 3 - Maximum Dose Carfilzomib 36 mg/m^2
- description
- Participants were administered 20 mg/m\^2 on days 1 and 2; 45 mg/m\^2 of Carfilzomib on days 6 and 7.
- id
- BG003
- title
- Dose Level 4 - Maximum Dose Carfilzomib 45 mg/m^2
- description
- Total of all reporting groups
- id
- BG004
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 29
- upper Limit
- 60
- value
- 32
- group Id
- BG001
- lower Limit
- 51
- upper Limit
- 61
- value
- 55
- group Id
- BG002
- lower Limit
- 26
- upper Limit
- 69
- value
- 58
- group Id
- BG003
- lower Limit
- 53
- upper Limit
- 64
- value
- 60
- group Id
- BG004
- lower Limit
- 26
- upper Limit
- 69
- value
- 58
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 22
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 24
- title
- Female
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 19
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 27
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 39
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 49
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 2
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle